Jeanna Parsons Leigh, Emily A FitzGerald, Stephana Julia Moss, Michal S Cherak, Rebecca Brundin-Mather, Alexandra Dodds, Henry T Stelfox, Ève Dubé, Kirsten M Fiest, Donna M Halperin, Sofia B Ahmed, Shannon E MacDonald, Sharon E Straus, Terra Manca, Josh Ng Kamstra, Andrea Soo, Shelly Longmore, Shelly Kupsch, Bonnie Sept, Scott A Halperin
The evolution of vaccine hesitancy through the COVID-19 pandemic: A semi-structured interview study on booster and bivalent doses
Human vaccines & immunotherapeutics
commercial rates free flap reconstruction known publicly 2021 hospital price transparency final rule purpose study examine commercial facility payments characterize nationwide variation microsurgical operations identify opportunities improve market effectiveness crosssectional study performed using 2022 commercial insurance pricing merged hospital performance data facility payment rates extracted nine cpt codes free flap operations price variation quantified means acrosshospital ratios withinhospital ratios mixed effects linear models evaluated commercial rates relative value outcomes equity performance metrics addition facilitylevel factors included health care market concentration total 20528 commercial rates across 675 hospitals compiled acrosshospital ratios ranged 585 795 whereas withinhospital ratios ranged 100 171 compared lowest scoring hospitals grade hospitals outcome grade equity grades b c associated higher commercial rates p 004 significant differences rate based value higher commercial rates also associated nonprofit status concentrated markets p 0006 lower commercial rates correlated safetynet teaching hospitals p 0001 commercial rates free flaps varied substantially across within hospitals associations higher commercial rates less competitive markets lack consistent association value equity identify market failures additional work needed improve market efficiency free flap operations